Worth Watching Stock: Magellan Health, Inc.(NASDAQ:MGLN): Apollo Commercial Real Estate Finance(NYSE:ARI)

0
4

Magellan Health, Inc. (MGLN) will report its next earnings on Feb 28 BMO. The company reported the earnings of $-0.77/Share in the last quarter where the estimated EPS by analysts was $1.65/share. The difference between the expected and actual EPS was $-2.42/share, which represents an Earnings surprise of -146.7%.

Many analysts are providing their Estimated Earnings analysis for Magellan Health, Inc. and for the current quarter 4 analysts have projected that the stock could give an Average Earnings estimate of $0.58/share. These analysts have also projected a Low Estimate of $0.42/share and a High Estimate of $0.73/share.

In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for Magellan Health, Inc. as 1.74 Billion. According to these analysts, the Low Revenue Estimate for Magellan Health, Inc. is 1.72 Billion and the High Revenue Estimate is 1.76 Billion. The company had Year Ago Sales of 1.81 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for MGLN to be -25.9%. They are projecting Next Quarter growth of -6.52%. For the next 5 years, Magellan Health, Inc. is expecting Growth of 26.63% per annum, whereas in the past 5 years the growth was 62.6% per annum.

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Magellan Health, Inc. might touch $84 high while the Average Price Target and Low price Target is $77 and $71 respectively.

Magellan Health, Inc. closed its last trading session at $66.15 with the loss of -2.3%. The Market Capitalization of the company stands at 1.55 Billion. The Company has 52-week high of $112.25 and 52-week low of $51.88. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -2.71% where SMA50 and SMA200 are -0.12% and -9.58% respectively. The Company Touched its 52-Week High on 04/19/18 and 52-Week Low on 12/06/18.

The Relative Volume of the company is 0.71 and Average Volume (3 months) is 311.07 million. The company’s P/E (price to earnings) ratio is 70.25 and Forward P/E ratio of 13.

The company shows its Return on Assets (ROA) value of 0.8%. The Return on Equity (ROE) value stands at 1.8%. While it’s Return on Investment (ROI) value is 2.2%.

While looking at the Stock’s Performance, Magellan Health, Inc. currently shows a Weekly Performance of 0.25%, where Monthly Performance is -8.33%, Quarterly performance is 15.29%, 6 Months performance is -11.47% and yearly performance percentage is -39.51%. Year to Date performance value (YTD perf) value is 13.61%. The Stock currently has a Weekly Volatility of 3.01% and Monthly Volatility of 3.43%.

Apollo Commercial Real Estate Finance (ARI) will report its next earnings on Feb 13 AMC. The company reported the earnings of $0.46/Share in the last quarter where the estimated EPS by analysts was $0.46/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.

Many analysts are providing their Estimated Earnings analysis for Apollo Commercial Real Estate Finance and for the current quarter 8 analysts have projected that the stock could give an Average Earnings estimate of $0.47/share. These analysts have also projected a Low Estimate of $0.46/share and a High Estimate of $0.49/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Apollo Commercial Real Estate Finance as 81.78 Million. According to these analysts, the Low Revenue Estimate for Apollo Commercial Real Estate Finance is 79.2 Million and the High Revenue Estimate is 90.5 Million. The company had Year Ago Sales of 63.23 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for ARI to be 9.3%. They are projecting Next Quarter growth of 9.09%. For the next 5 years, Apollo Commercial Real Estate Finance is expecting Growth of 4.45% per annum, whereas in the past 5 years the growth was 7.3% per annum.

Some buy side analysts are also providing their Analysis on Apollo Commercial Real Estate Finance, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Apollo Commercial Real Estate Finance might touch $19 high while the Average Price Target and Low price Target is $18.3 and $18 respectively.

Apollo Commercial Real Estate Finance closed its last trading session at $18.43 with the loss of -0.38%. The Market Capitalization of the company stands at 2.46 Billion. The Company has 52-week high of $19.57 and 52-week low of $16.41. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 0.73% where SMA50 and SMA200 are 1.68% and -0.99% respectively. The Company Touched its 52-Week High on 09/04/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.93 and Average Volume (3 months) is 1.05 million. The company’s P/E (price to earnings) ratio is 12.54 and Forward P/E ratio of 9.44.

The company shows its Return on Assets (ROA) value of 3.9%. The Return on Equity (ROE) value stands at 7.8%. While it’s Return on Investment (ROI) value is 4.6%.

While looking at the Stock’s Performance, Apollo Commercial Real Estate Finance currently shows a Weekly Performance of -0.43%, where Monthly Performance is 1.72%, Quarterly performance is 2.74%, 6 Months performance is -4.18% and yearly performance percentage is -0.76%. Year to Date performance value (YTD perf) value is 10.2%. The Stock currently has a Weekly Volatility of 1.12% and Monthly Volatility of 1.01%.

SHARE